Evaluation of effectiveness of glucocorticoid treatment using a rat acute hepatic failure model

Kanzo/Acta Hepatologica Japonica

Volumn 40, Issue 4, 1999, Pages 217-226

  Sato, Akihiro ^a   Takikawa, Yasuhiro ^a   Sato, Shinichiro ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GALACTOSAMINE; GLUCOCORTICOID; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONOTHERAPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER HISTOLOGY; LIVER PROTECTION; NONHUMAN; RAT;

EID: 0033017246     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.40.217     Document Type: Article

References (28)

1. Almeida JD, Waterson AP: Immune complexes in hepatitis. Lancet 2 : 983-986, 1986
2. Duddley FJ, Fox RA, Sherlock S: Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet 1 : 723-726, 1972
3. Ware A, Jones R, Shorey J, et al: A controlled trial of steroid therapy in massive hepatic necrosis. Am J Gastroenterol 2 : 130-133, 1974
4. Report from the EASL: Randomized trial of steroid therapy in acute liver failure. Gut 20 : 620-623, 1979
5. Rakela J: A double-blind randomized trial of hydrocortisone in acute hepatic failure. Gastroenterology 76 : 1279, 1979
6. Cnales J, Gimson A, Davis C, et al: Controlled trial of dexamethasone and mannitol for the cerebral oedma of fulminant hepatic failure, Gut 23 : 625-629, 1982
7. Muto Y, Nouri-Aria KT, Meager A, et al: Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure, Lancet 2 : 72-74, 1988
8. Mochida S, Ohno A, Arai M, et al: Role of adhesion between activated macrophages and endothelial cells in the development of two types of massive hepatic necrosis in rats. J Gastroenterol Hepatol 10 : S38, 1995
9. Takeuchi M, Nakashima Y, Miura Y, et al: The localization of lipopolysaccharide in an endotoxinemic rat liver and its relation to sinusoidal thrombogenesis : Light and electron microscopic studies. Path Res Pract 190 : 1123-1133, 1994
10. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al: Lethal effect of the anti-Fas antibody in mice. Nature 364 : 806-809, 1993
11. Leist M, Gantner F, Bohlinger I, et al: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146 : 1220-1234, 1995
12. M Yoshiba, K Sekiyama, K Inoue, et al : Interferon and cyclosporin A in the treatment of fulminat viral hepatitis. Gastroenterology 30 : 67-73, 1995
13. Minophagen Medical Review 40 : 156-157, 1995
14. Morikawa A, Sugiyama T, Koide N, et al: Apoptotic cell death in response of D -galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic Shock model. Infect Immun 64 : 734-738, 1996
15. Beutler BA, Krochin N, Milsark LW, et al: Control of cachectin (tumor necrosis factor) synthesis : mechanism of endotoxin resistance. Science 232 : 977-980, 1986
16. Ray A, Laforge KS, Sehgal PB: On the mechanism for efficient repression of Interleukin-6 promotor by glucocorticoids : Enhancer, TATA box, and RNA start site(Inr Motif) occlusion. Mol Cell Biol 10 : 5736-5746, 1990
17. Simon W, Lee Tsou A-P, et al: Glucocorticoids selectively inhibit the transcription of the interleukin 1b gene and decrease the stability of interleukin 1b m RNA. Proc Natl Acad Sci USA 85 : 1204-1208, 1988
18. Hart PH, Vitti GF, Burgess DR, et al: Potential antiinflamatory effects of interleukin 4 : Suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86 : 3803-3807, 1989
19. Luedke CE, Cerami A: Interferon-γ Overcomes glucocorticoid suppression of Cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest 86 : 1240-1243, 1990
20. van der Poll T, Levi M, van Deventer SJH, et al: Differential effects of anti-tumor necrosis factor monocronal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 83 : 446-451, 1994